Lpl Financial LLC Oncolytics Biotech Inc Transaction History

Lpl Financial LLC

  • $238 Billion
  • Q4 2024

A detailed history of Lpl Financial LLC transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Lpl Financial LLC holds 16,022 shares of ONCY stock, worth $12,336. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,022
Previous 20,522 21.93%
Holding current value
$12,336
Previous $17,000 17.65%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$0.74 - $1.4 $3,330 - $6,300
-4,500 Reduced 21.93%
16,022 $14,000
Q3 2024

Nov 08, 2024
BUY
$0.87 - $1.08 $11 - $14
13 Added 0.06%
20,522 $17,000
Q2 2024

Aug 07, 2024
BUY
$0.99 - $1.24 $2,475 - $3,100
2,500 Added 13.88%
20,509 $20,000
Q1 2024

May 10, 2024
SELL
$0.89 - $1.36 $1,397 - $2,135
-1,570 Reduced 8.02%
18,009 $19,000
Q4 2023

Feb 14, 2024
SELL
$1.22 - $2.09 $2,440 - $4,180
-2,000 Reduced 9.27%
19,579 $26,000
Q3 2023

Nov 13, 2023
BUY
$1.98 - $3.24 $42,726 - $69,915
21,579 New
21,579 $47,000
Q2 2022

Aug 12, 2022
SELL
$0.85 - $1.59 $4,250 - $7,950
-5,000 Reduced 23.24%
16,512 $17,000
Q1 2022

May 16, 2022
BUY
$1.31 - $2.02 $1,310 - $2,020
1,000 Added 4.88%
21,512 $34,000
Q4 2021

Feb 14, 2022
BUY
$1.39 - $2.3 $31 - $52
23 Added 0.11%
20,512 $29,000
Q3 2021

Nov 15, 2021
BUY
$1.93 - $2.77 $16,460 - $23,625
8,529 Added 71.31%
20,489 $43,000
Q2 2021

Aug 13, 2021
SELL
$2.6 - $4.64 $1,430 - $2,552
-550 Reduced 4.4%
11,960 $33,000
Q1 2021

May 14, 2021
BUY
$2.32 - $4.11 $2,320 - $4,110
1,000 Added 8.69%
12,510 $48,000
Q4 2020

Feb 12, 2021
SELL
$1.71 - $4.03 $3,420 - $8,060
-2,000 Reduced 14.8%
11,510 $27,000
Q2 2020

Aug 13, 2020
BUY
$1.33 - $2.76 $17,968 - $37,287
13,510 New
13,510 $25,000

Others Institutions Holding ONCY

# of Institutions
48
Shares Held
1.45M
Call Options Held
0
Put Options Held
0
View Full List

About ONCOLYTICS BIOTECH INC

ONCY Quotes by TradingView
  • Ticker ONCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,867,400
  • Market Cap $44.6M
  • Description
  • Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...
More about ONCY
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email